Franklin Moore, DO
Internal Medicine · South Charleston, WVNPI 1013931443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 530 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 530 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$1K
- Lilly USA, LLC$1K
- AbbVie$884
- Amgen$692
- Dexcom, Inc.$556
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 111 | $1,366 |
| AstraZeneca | 59 | $1,017 |
| Lilly USA, LLC | 69 | $1,007 |
| AbbVie(2 entities) | 54 | $884 |
| Amgen | 50 | $692 |
| Dexcom, Inc. | 19 | $556 |
| Boehringer Ingelheim | 21 | $331 |
| Merck | 16 | $252 |
| Novartis | 12 | $203 |
| Kowa Pharmaceuticals America, Inc. | 14 | $161 |
| GSK | 11 | $158 |
| Exact Sciences | 9 | $149 |
| Amarin Pharma, Inc. | 10 | $145 |
| Johnson & Johnson | 9 | $134 |
| Pfizer | 8 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $109 |
| Bayer | 7 | $106 |
| Teva Pharmaceuticals USA, Inc. | 7 | $102 |
| Sanofi-aventis U.S. LLC | 6 | $87 |
| Phathom Pharmaceuticals, Inc. | 5 | $77 |
| Sunovion Pharmaceuticals Inc. | 4 | $63 |
| Esperion Therapeutics, Inc. | 4 | $53 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Scynexis, Inc. | 1 | $33 |
| Lexicon Pharmaceuticals, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $28 |
| Abbott | 2 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Heartflow, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,086 in reported general payments places this provider in the 95th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $177,173 |
| JanuviaSitagliptin Phosphate | 96 | $145,569 |
| OzempicSemaglutide | 73 | $108,555 |
| JardianceEmpagliflozin | 40 | $54,680 |
| RybelsusSemaglutide | 31 | $53,865 |
| EntrestoSacubitril/Valsartan | 37 | $47,374 |
| XareltoRivaroxaban | 36 | $44,971 |
| FarxigaDapagliflozin Propanediol | 26 | $38,870 |
| LinzessLinaclotide | 26 | $21,964 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $21,358 |
| TradjentaLinagliptin | 27 | $21,191 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $14,493 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $13,226 |
| Novolog Mix 70-30Insulin Aspart Prot/Insuln Asp | 17 | $12,074 |
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 16 | $8,656 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $114 | $177,173123 claims |
| Novo NordiskOzempic, Rybelsus, Novolog Mix 70-30 | $1,366 | $174,493121 claims |
| MerckJanuvia | $252 | $145,56996 claims |
| Boehringer IngelheimJardiance, Tradjenta | $331 | $75,87167 claims |
| NovartisEntresto | $203 | $47,37437 claims |
| Johnson & JohnsonXarelto | $134 | $44,97136 claims |
| AstraZenecaFarxiga, Symbicort | $1,017 | $44,86637 claims |
| AbbVieLinzess, Synthroid | $884 | $26,28587 claims |
| GSKBreo Ellipta | $158 | $14,49319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 internal medicine providers in West Virginia.
Other internal medicine in South Charleston
- Dina CrinitiSouth Charleston$12K
- William ChapmanCharleston$1.7M
- David PickeringParkersburg$599K
- Govind PatelFairmont$59K
- Bisher MustafaHuntington$28K
- Johny AlencherryMartinsburg$27K
- Ali KhanBuckhannon$21K
- Joseph HashemBerkeley Springs$21K
- David PatickHuntington$18K
- Phillip TriplettCharleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.